repaglinide has been researched along with Insulin Sensitivity in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, Y; Liu, LY; Liu, W; Ma, J; Tao, T; Wu, PH | 1 |
| Adelusi, TI; Bao, Z; Li, W; Lu, Q; Lv, D; Shang, Z; Song, J; Sun, J; Wang, T; Wang, Y; Yin, X; Zhou, X; Zhu, J | 1 |
| Amin, MM; Arbid, MS | 1 |
| Bao, YQ; Hu, C; Jia, WP; Lu, JY; Qin, W; Wang, CR; Xiang, KS; Yu, WH; Zhang, R | 1 |
| Chu, YM; Hsia, TL; Hsiao, FC; Hsieh, AT; Lee, LH; Lin, JD; Pei, C; Pei, D; Wang, K; Wu, CZ | 1 |
| Bao, Y; Hu, C; Jia, W; Jiang, F; Lu, J; Qin, W; Tang, S; Wang, C; Xiang, K; Yu, W; Zhang, R | 1 |
| Buysschaert, M; de la Tribonnière, X; Hermans, MP; Oriot, P; Selvais, P | 1 |
| Pørksen, N | 1 |
| Blicklé, JF | 1 |
| Morley, JE | 1 |
| Smits, P; Tack, CJ | 1 |
| Bailey, CJ; Nattrass, M | 1 |
| Garber, AJ | 1 |
| Kock, M | 1 |
| Calvo Romero, JM; Lima Rodríguez, EM | 1 |
6 review(s) available for repaglinide and Insulin Sensitivity
| Article | Year |
|---|---|
Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes.
Topics: Carbamates; Circadian Rhythm; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Pancreas; Piperidines; Predictive Value of Tests; Pulsatile Flow | 2002 |
The elderly Type 2 diabetic patient: special considerations.
Topics: Aged; Amyloid; Blood Glucose; Carbamates; Cognition Disorders; Depression; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Islet Amyloid Polypeptide; Male; Piperidines | 1998 |
New drugs for diabetes.
Topics: Carbamates; Chromans; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Nateglinide; Phenylalanine; Piperidines; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
New agents for Type 2 diabetes.
Topics: Anti-Obesity Agents; Carbamates; Chromans; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Insulin Resistance; Piperidines; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
The importance of early insulin secretion and its impact on glycaemic regulation.
Topics: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Eating; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Piperidines; Time Factors | 2000 |
[Objectives and therapeutic strategy in type 2 diabetes mellitus].
Topics: Carbamates; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Piperidines; Thiazoles | 2001 |
4 trial(s) available for repaglinide and Insulin Sensitivity
| Article | Year |
|---|---|
Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China.
Topics: Body Mass Index; Carbamates; China; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Drug Monitoring; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Overweight; Piperidines; Weight Loss | 2014 |
A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients.
Topics: Adult; Asian People; Carbamates; China; Diabetes Mellitus, Type 2; Female; Hep G2 Cells; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; KCNQ1 Potassium Channel; Male; Middle Aged; Phosphatidylinositol 3-Kinases; Piperidines; Polymorphism, Genetic; Proto-Oncogene Proteins c-akt; Signal Transduction | 2016 |
Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gliclazide; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Piperidines; Time Factors; Treatment Outcome | 2010 |
Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.
Topics: Administration, Oral; Adult; Alleles; Asian People; Blood Glucose; Carbamates; China; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; KCNQ1 Potassium Channel; Male; Middle Aged; Pharmacogenetics; Piperidines; Polymorphism, Single Nucleotide; Rosiglitazone; Thiazolidinediones | 2011 |
5 other study(ies) available for repaglinide and Insulin Sensitivity
| Article | Year |
|---|---|
Estimation of ellagic acid and/or repaglinide effects on insulin signaling, oxidative stress, and inflammatory mediators of liver, pancreas, adipose tissue, and brain in insulin resistant/type 2 diabetic rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers; Brain; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ellagic Acid; Hyperglycemia; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Intra-Abdominal Fat; Liver; Male; Neurons; Oxidative Stress; Pancreas; Piperidines; Rats, Wistar | 2017 |
A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
Topics: Adaptor Proteins, Signal Transducing; Carbamates; China; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Piperidines; Polymorphism, Single Nucleotide | 2010 |
Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy.
Topics: Adipose Tissue; Antiretroviral Therapy, Highly Active; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; HIV Infections; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Peptides; Piperidines; Venoms; Waist Circumference; Weight Loss | 2011 |
[Type 2 diabetes mellitus pathogenesis: new therapeutic managements?].
Topics: Carbamates; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Piperidines; Treatment Outcome | 2003 |
Insulin secretagogues.
Topics: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Piperidines | 1997 |